Sugammadex Titration in Cardiac Surgery Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT05246397
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT05246397
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05246397. Allocation not applicable; no masking; primary purpose other. Start 2022-02-01 (actual); primary completion 2022-11-10 (actual). Results posted on 2024-03-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sugammadex Titration in Cardiac Surgery Patients
- Condition
- Coronary Artery Disease
- Condition
- Valvular Heart Disease
- Condition
- Aorta Disease
- Condition
- Heart Failure
- Intervention (Drug)
- Sugammadex administration
- Lead sponsor
- University of Washington
Record details
- Record id
cardio:ct-nct05246397- Content hash
fd530de2a80c7f2911a79b15089e5ab12f2164b955092e4a3da10f9f95e5e473